From February 18, 2024 to March 31, 2024, the company has repurchased 392,167 shares, representing 0.98% for CNY 11.7 million. With this, the company has completed the repurchase of 392,167 shares, representing 0.98% for CNY 11.7 million under the buyback announced on February 19, 2024.
Shanghai Rendu Biotechnology Co., Ltd.
Equities
688193
CNE1000059K5
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.86 CNY | +2.05% | +1.35% | -24.96% |
1st Jan change | Capi. | |
---|---|---|
-24.96% | 184M | |
-5.43% | 182B | |
+4.30% | 114B | |
-3.09% | 68.38B | |
+5.86% | 52.46B | |
+8.15% | 44.25B | |
+7.52% | 43.55B | |
+25.54% | 32.69B | |
+17.85% | 26.73B | |
+1.00% | 25.79B |
- Stock Market
- Equities
- 688193 Stock
- News Shanghai Rendu Biotechnology Co., Ltd.
- Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.